Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Triple Negative Breast Neoplasms

moxifloxacin has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Beberok, A; Boryczka, S; Marciniec, K; Rok, J; Rzepka, Z; WrzeĊ›niok, D1

Other Studies

1 other study(ies) available for moxifloxacin and Triple Negative Breast Neoplasms

ArticleYear
Interaction between moxifloxacin and Mcl-1 and MITF proteins: the effect on growth inhibition and apoptosis in MDA-MB-231 human triple-negative breast cancer cells.
    Pharmacological reports : PR, 2022, Volume: 74, Issue:5

    Topics: Apoptosis; Cell Line, Tumor; Humans; Microphthalmia-Associated Transcription Factor; Molecular Docking Simulation; Moxifloxacin; Triple Negative Breast Neoplasms

2022